Production (Stage)
Coya Therapeutics, Inc.
COYA
$5.45
-$0.18-3.20%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 35.53M | 38.34M | 31.06M | 36.58M | 35.99M |
| Total Receivables | -- | 730.60K | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 2.84M | 5.24M | 4.45M | 3.31M | 1.35M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 38.37M | 44.31M | 35.51M | 39.89M | 37.33M |
|
|
|||||
| Total Current Assets | 38.37M | 44.31M | 35.51M | 39.89M | 37.33M |
| Net Property, Plant & Equipment | 31.70K | 38.60K | 45.40K | 52.30K | 59.10K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 38.41M | 44.35M | 35.55M | 39.94M | 37.39M |
|
|
|||||
| Total Accounts Payable | 1.69M | 1.59M | 336.70K | 1.88M | 1.59M |
| Total Accrued Expenses | 1.81M | 1.39M | 1.41M | 1.00M | 1.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 841.40K | 848.30K | 573.10K | 939.00K | 1.41M |
| Total Other Current Liabilities | 841.40K | 848.30K | 573.10K | 939.00K | 1.41M |
| Total Current Liabilities | 4.34M | 3.82M | 2.32M | 3.83M | 4.32M |
|
|
|||||
| Total Current Liabilities | 4.34M | 3.82M | 2.32M | 3.83M | 4.32M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 694.40K | 945.40K | 1.22M | 856.70K | 681.30K |
| Total Liabilities | 5.04M | 4.77M | 3.54M | 4.68M | 5.00M |
|
|
|||||
| Common Stock & APIC | 81.41M | 80.31M | 69.83M | 69.06M | 63.45M |
| Retained Earnings | -48.04M | -40.74M | -37.82M | -33.80M | -30.91M |
| Treasury Stock & Other | -- | -- | -- | -- | -149.30K |
| Total Common Equity | 33.37M | 39.58M | 32.01M | 35.26M | 32.39M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 33.37M | 39.58M | 32.01M | 35.26M | 32.39M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 33.37M | 39.58M | 32.01M | 35.26M | 32.39M |
|
|
|||||